The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) pyrrolotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.
本发明提供了式(I)化合物及其药学上可接受的盐。式(I)中的
吡咯并三嗪抑制蛋白激酶活性,因此可用作抗癌剂。